Quick answer: does Medicare cover Ozempic? Yes, for type 2 diabetes. Most Medicare Part D drug plans cover it, usually with prior authorization to confirm diabetes.[2] No, for weight loss alone: Part D law excludes weight-loss drugs, and Ozempic is not part of the $50-a-month Medicare GLP-1 Bridge that began July 1, 2026.[3][6] Medicare’s negotiated price of $274 a month for Ozempic takes effect January 1, 2027.[9]

Prices and program terms checked October 2026. They change often; confirm with the manufacturer or your plan.

Ozempic is a weekly injection, and now also a daily pill, containing semaglutide. Its label covers blood sugar control in type 2 diabetes, plus heart and kidney protection in people with type 2 diabetes.[1]

Part D coverage for type 2 diabetes

Medicare covers outpatient prescription drugs through Part D, either as a stand-alone drug plan or within a Medicare Advantage plan. Because Ozempic is approved for type 2 diabetes, it can be covered for that use, and Novo Nordisk notes that most Medicare drug plans cover it.[2]

Expect these plan rules:

  • Prior authorization to confirm a type 2 diabetes diagnosis, often with an A1C result.
  • Quantity limits based on the dose.
  • A formulary tier that sets your coinsurance.

The heart and kidney uses on the label apply to people who also have type 2 diabetes, so they are covered under the same Part D rules.[1]

Why Medicare won’t cover Ozempic for weight loss

The Part D statute excludes “agents when used for weight loss.” Anti-obesity medicines can be covered only for other approved uses, such as type 2 diabetes or cardiovascular disease.[3]

In November 2024, CMS proposed reinterpreting that exclusion to cover obesity drugs.[3] On April 4, 2025, CMS said it was not finalizing that proposal.[4] The statutory exclusion still stands, which is why later changes were built as separate programs rather than regular Part D coverage.

What changed in 2025 and 2026

ChangeDateWhat it means for Ozempic
Trump administration deals with Novo Nordisk and Eli LillyAnnounced Nov 6, 2025Medicare price of $245 for Ozempic, Wegovy, Mounjaro and Zepbound[7]
Medicare GLP-1 BridgeJuly 1, 2026 to Dec 31, 2027$50 a month for Wegovy, Zepbound KwikPen and Foundayo for weight loss; Ozempic not included[5][6]
BALANCE model in Part DDelayed indefinitely (April 21, 2026)No Part D obesity coverage through BALANCE in 2027[8]
Negotiated (IRA) priceJan 1, 2027$274 per 30-day supply for Ozempic, Rybelsus and Wegovy[9]
Novo Nordisk list price cutJan 1, 2027List price falls to $675 a month[13]

The Medicare GLP-1 Bridge

The Bridge is a temporary CMS demonstration for weight management. Eligible Part D enrollees aged 18 or older pay a $50 copay per month for Wegovy, Zepbound (KwikPen only) or Foundayo if they have a BMI of 35 or higher, or a lower BMI with certain conditions.[5]

People with type 2 diabetes, moderate to severe sleep apnea or MASH are not eligible, because their plan should cover GLP-1s for those conditions.[5] So if you take Ozempic for diabetes, you stay with your Part D plan. CMS also excludes people who already received a GLP-1 through Part D in 2026 from the Bridge that year.[6]

The negotiated price

Semaglutide was among the 15 drugs in the second round of Medicare drug price negotiation. CMS set a price of $274 for a 30-day supply of Ozempic, Rybelsus or Wegovy, starting January 1, 2027. That is 71% below the 2024 list price of $959. About 2.3 million Part D enrollees used these drugs in 2024.[9]

Which Medicare path applies to you

Semaglutide now reaches Medicare enrollees through two separate doors, and which one you use depends on your diagnosis, not on the brand you prefer:

  • You have type 2 diabetes. Ozempic (or another diabetes GLP-1) goes through your Part D plan, with its prior authorization, tier and coinsurance. You are not eligible for the Bridge.[5]
  • You have heart disease and overweight or obesity, without diabetes. Wegovy prescribed to lower cardiovascular risk is a Part D-covered use, so the prescription is routed to your plan.[6]
  • You have obesity without diabetes, sleep apnea or MASH. You may qualify for Wegovy, Zepbound KwikPen or Foundayo through the Bridge at $50 a month, if you meet its BMI and condition criteria.[5]
  • You want Ozempic for weight loss only. Neither door applies. Part D will not cover it, and the Bridge does not include Ozempic.[3][5]

Medicare Advantage plans that include drug coverage follow the same Part D rules as stand-alone drug plans, though each plan sets its own drug list and prior authorization forms. Your plan cannot approve or deny Bridge requests; your prescriber sends those to CMS, and refills do not need a new approval unless you switch drugs.[5]

If you already used a GLP-1 through your Part D plan earlier in 2026, CMS will not enroll you in the Bridge for the rest of 2026.[6] Plan any switch with your prescriber, who also sets the dose.

What you will pay in 2026

Your cost depends on your plan’s tier and design. Under the 2026 standard Part D benefit:[10]

PhaseYou pay
Deductible100% until you spend $615
Initial coverage25% until your out-of-pocket costs reach $2,100
Catastrophic$0 for the rest of the year

Two programs can help:

  • Medicare Prescription Payment Plan spreads your drug costs into monthly bills instead of large payments early in the year.[10]
  • Extra Help (the Low-Income Subsidy) removes out-of-pocket drug costs at full subsidy for people with income at or below 150% of the federal poverty level.[10]

You cannot use Novo Nordisk’s Ozempic savings card with Medicare,[11] and Medicare beneficiaries with drug coverage can no longer get Ozempic through Novo Nordisk’s Patient Assistance Program.[2]

If your plan denies Ozempic

  1. Ask for a coverage determination or exception. The plan must decide within 72 hours of receiving your prescriber’s supporting statement, or 24 hours if expedited.[12]
  2. Request a redetermination (the first appeal level) if it still says no.[12]
  3. Go to independent review if the plan upholds its denial.[12]

A denial is likely to stick if the prescription is for weight loss without type 2 diabetes. In that case, ask your prescriber whether you qualify for the Bridge with Wegovy.